Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry


5 Market Segmentation
5.1 By product
5.1.1 By Monitoring Devices (Value and Volume, 2012-2025)
5.1.1.1 Self-monitoring Blood Glucose Devices
5.1.1.1.1 Glucometer Devices
5.1.1.1.2 Blood Glucose Test Strips
5.1.1.1.3 Lancets
5.1.1.2 Continuous Glucose Monitoring
5.1.1.2.1 Sensors
5.1.1.2.2 Durables
5.1.2 By Management Devices (Value and Volume, 2012-2025)
5.1.2.1 Insulin Pump
5.1.2.1.1 Insulin Pump Device
5.1.2.1.2 Insulin Pump Reservoir
5.1.2.1.3 Infusion Set
5.1.2.2 Insulin Syringes
5.1.2.3 Cartridges in Reusable pens
5.1.2.4 Insulin Disposable Pens
5.1.2.5 Jet Injectors
5.2 Geography
5.2.1 North America (Volume and Value, 2012-2025)
5.2.1.1 United States
5.2.1.1.1 By Monitoring Devices
5.2.1.1.2 By Management Devices
5.2.1.2 Canada
5.2.1.2.1 By Monitoring Devices
5.2.1.2.2 By Management Devices
5.2.1.3 Rest of North America
5.2.1.3.1 By Monitoring Devices
5.2.1.3.2 By Management Devices


6 Market Indicators
6.1 Type-1 Diabetes Population (2012-2025)
6.2 Type-2 Diabetes Population (2012-2025)


7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Becton, Dickinson and Company
7.1.2 Medtronic
7.1.3 F. Hoffmann-La Roche AG
7.1.4 Insulet
7.1.5 Abbott
7.1.6 Dexcom
7.1.7 Tandem
7.1.8 Ypsomed
7.1.9 Novo Nordisk
7.1.10 Sanofi
7.1.11 Eli Lilly


8 MARKET OPPORTUNITIES AND FUTURE TRENDS